Zahi Mitri, MD, MS, is a medical oncologist specializing in breast oncology and translational cancer research. He serves as Medical Oncology Faculty at BC Cancer and Clinical Associate Professor of Medicine at the University of British Columbia in Vancouver, and is the Scientific Lead of the Clinical Research Unit at BC Cancer – Vancouver; he also holds an adjunct faculty appointment at Oregon Health & Science University. Clinically, his work centers on breast oncology, biomarker-driven personalized therapeutics, and care for young and high-risk populations. Dr. Mitri’s research focuses on biomarker discovery and predictive modeling to guide therapy selection, elucidating mechanisms of therapeutic resistance, and advancing novel targeted and antibody–drug conjugate strategies through clinical trials. His leadership includes serving as Scientific Lead of the Clinical Research Unit at BC Cancer – Vancouver and previously as Program Director for Breast Oncology at the OHSU Knight Cancer Institute. He earned his medical degree from the American University of Beirut Faculty of Medicine, completed fellowship training in hematology/medical oncology at MD Anderson Cancer Center, and received a Master of Science in Clinical and Translational Sciences from the UT Graduate School of Biomedical Sciences.
Medical School
Residency
2013
Fellowship
2013 – 2016